Shell Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$19K Sell
2,222
-3,066
-58% -$29.8K ﹤0.01% 1042
2025
Q2
$60K Sell
5,288
-568
-10% -$5.22K ﹤0.01% 1113
2025
Q1
$55K Sell
5,856
-248
-4% -$2.5K ﹤0.01% 1133
2024
Q4
$69K Hold
6,104
﹤0.01% 1122
2024
Q3
$173K Buy
+6,104
New +$157K 0.01% 893
2024
Q1
$121K Sell
6,321
-12,169
-66% -$388K 0.01% 969
2023
Q4
$611K Sell
18,490
-4,965
-21% -$140K 0.03% 446
2023
Q3
$639K Buy
23,455
+2,626
+13% +$73K 0.03% 470
2023
Q2
$631K Buy
20,829
+11,570
+125% +$374K 0.02% 500
2023
Q1
$300K Sell
9,259
-32
-0.3% -$1.01K 0.01% 783
2022
Q4
$261K Sell
9,291
-1,956
-17% -$56.1K 0.01% 836
2022
Q3
$404K Sell
11,247
-2,945
-21% -$104K 0.02% 680
2022
Q2
$436K Buy
14,192
+25
+0.2% +$729 0.01% 784
2022
Q1
$458K Sell
14,167
-2,096
-13% -$54.9K 0.01% 853
2021
Q4
$450K Buy
16,263
+83
+0.5% +$2.38K 0.01% 949
2021
Q3
$502K Sell
16,180
-700
-4% -$16.8K 0.01% 864
2021
Q2
$357K Buy
16,880
+10,801
+178% +$216K 0.01% 1060
2021
Q1
$123K Hold
6,079
﹤0.01% 1250
2020
Q4
$97K Hold
6,079
﹤0.01% 1272
2020
Q3
$75K Hold
6,079
﹤0.01% 1212
2020
Q2
$43K Buy
+6,079
New +$40.7K ﹤0.01% 1271

Other funds holding EVH

Shell Asset Management's EVH Position: Q3 2025 in Review

Shell Asset Management reduced its Evolent Health (EVH) stake by 58% in Q3 2025, selling an estimated $29.8K and leaving 2,222 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

Shell Asset Management first reported a position in EVH in Q2 2020 and has held it in 21 quarters since. The position peaked at $639K in Q3 2023. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Shell Asset Management held 2,222 shares of Evolent Health worth $19K as of Q3 2025.
  • Shell Asset Management sold 3,066 Evolent Health shares in Q3 2025, an estimated $29.8K.
  • Evolent Health made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1042 holding.
  • Shell Asset Management first reported a position in Evolent Health in Q2 2020 and has held it in 21 quarters since.
  • Shell Asset Management's Evolent Health position peaked at $639K in Q3 2023.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.